Neurosarcoidosis


Article Author:
Letitia Pirau


Article Editor:
Forshing Lui


Editors In Chief:
Michael Labanowski


Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Frank Smeeks
Kristina Soman-Faulkner
Trevor Nezwek
Radia Jamil
Patrick Le
Sobhan Daneshfar
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Pritesh Sheth
Hassam Zulfiqar
Navid Mahabadi
Steve Bhimji
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Mark Pellegrini
James Hughes
Beata Beatty
Nazia Sadiq
Hajira Basit
Phillip Hynes
Tehmina Warsi


Updated:
11/27/2018 12:29:59 PM

Introduction

Although the etiology is unknown, sarcoidosis is a systemic disease that results in the formation of granulomas. Classically, the granulomas in sarcoidosis are non-caseating granulomas, which may be found throughout lymph nodes and organs, including the brain and nervous system. About 5% to 10% of patients with sarcoidosis will have neurologic complications.[1][2] Although the majority of patients with sarcoidosis do not have symptoms, neurosarcoidosis may be life-threatening and tends to occur in cases with systemic involvement.

Etiology

Although the cause is unclear, sarcoidosis is believed to be a hyperactive immune response. Th1 cells stimulate the release of IL-2 and IFN-gamma which then activate macrophages. In turn, the inflammatory response induced by macrophages causes granuloma formation.

Epidemiology

The prevalence of sarcoidosis has been estimated to be about 152 to 215 per 100000.[3] About 5% to 10% of patients with sarcoidosis will have neurologic complications.[1] Regarding race, neurosarcoidosis has been documented more commonly within Africans and African descent.[4] However, about half of patients with sarcoidosis have systemic disease, with 30% to 70% who have concomitant neurologic signs when first diagnosed.

Pathophysiology

A variety of theories have been used to explain the etiology of neurosarcoidosis. Sarcoidosis affects the lymphoreticular system, characterized by cervical and mediastinal lymphadenopathy.  Due to the distribution of lymphatics, the spleen and liver can also be affected. Neurosarcoidosis results from sarcoid granulomas within the nervous system. Pathologically, lymphocytes, and mononuclear phagocytes surround a noncaseating epithelioid cell granuloma. Symptoms result from the location of where the granulomas lie in the nervous system. For example, granulomas in the muscle may cause myositis, while granulomas in the nerve within the perineurium and epineurium may cause axonal damage and as a result peripheral neuropathy. Nerve injury may cause diffuse polyneuropathy, mononeuritis multiplex, and polyradiculopathy due to spinal root sheath involvement.

Histopathology

The classical finding of sarcoidosis is noncaseating granulomas. Nerve biopsies demonstrate axonal degeneration with nerve atrophy. Myelin ovoids may be seen as a sign of demyelination.[5]

History and Physical

Common features of central or peripheral nervous system involvement include: cranial mononeuropathy involving the facial nerve, neuroendocrine dysfunction involving the hypothalamus (i.e. neurogenic diabetes insipidus), myelopathy or radiculopathy if the spinal cord is affected (in rare cases cauda equina polyradiculopathy may occur), hydrocephalus, meningitis, mononeuropathy, mononeuritis multiplex, carpal tunnel, and muscle involvement which may cause proximal myopathy and muscle atrophy. Symptoms of neurosarcoidosis may be multifocal, commonly seen first in the cranial nerves. The facial nerve is the most common cranial nerve affected, which may mimic Lyme disease. Heerfordt syndrome is a rare manifestation of neurosarcoidosis which presents with facial nerve palsy and the presence of parotid gland enlargement, anterior uveitis, and fever.[6] Carpal tunnel may also be more frequent in sarcoidosis patients than the rest of the population.[7] Another cranial nerve that may be affected is the vestibulocochlear nerve causing balance and hearing problems.[8] Cerebellar signs, such as ataxia, may be present with cerebellar involvement.[9] During the exam, it is important to assess for papilledema and mental status as psychiatric abnormalities may also occur. Chronic meningitis with basal meningeal involvement is a common manifestation of neurosarcoidosis. Meningitis may present with either leptomeningeal or pachymeningeal involvement. It is one of the several important causes of pachymeningitis.

In gathering a history, the first sign of neurosarcoidosis may be seizures, which generally confers a poor prognosis. Patients with simple partial or complex partial seizures may have a better prognosis in comparison to generalized tonic-clonic seizures.

Evaluation

Neurosarcoidosis should be considered in patients with sarcoidosis who develop neurologic abnormalities. However, the index of suspicion is lower and thus much more difficult in cases where a patient is not known to have sarcoid but has neurologic abnormalities. Unfortunately, there is no diagnostic marker for neurosarcoidosis. 

If neurosarcoidosis is suspected, it is important to assess for signs of systemic diseases, such as the skin, lymph nodes, and lungs. Tests to conduct include ophthalmologic exam (including optical coherence tomography), nasal/sinus examination, chest x-ray (for perihilar lymphadenopathy), angiotensin-converting enzyme (ACE) assay (not specific), and in rare cases a magnetic resonance, gallium or fluorodeoxyglucose emission tomographic scan for areas of inflammation that may be biopsied.

In evaluating peripheral neuropathy, it is important to rule out other common causes of neuropathy such as hyperglycemic states, vitamin deficiencies, kidney failure, and toxins. Thermal threshold testing may be used for small-fiber neuropathy.

Neurodiagnostic tests may help rule out other differentials such as infection and malignancy. The imaging of choice is a contrast-enhanced MRI. Typical findings are basal meningeal enhancement especially with contrast-enhancing lesions involving the hypothalamus, pituitary stalk, and adjacent tissues. (See MRI below). Gadolinium and fluid-attenuated inversion recovery (FLAIR) is helpful to identify T2 enhancement of nerve roots, plexuses, and nerves. Active inflammation may be seen with meningeal or parenchymal enhancement. Parenchymal, meningeal masses, and hydrocephalus may also be seen with MRI. 

As with other inflammatory states, ESR may be elevated. Creatinine kinase and aldolase may also be used to evaluate for myopathy. Liver function testing may also be abnormal, thereby reflecting the systemic involvement of sarcoidosis. If the pituitary-hypothalamic axis is affected, endocrine studies should be done. In recent years, F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) imaging have been used to evaluate for neurosarcoidosis. F-18 FDG PET/CT is gaining popularity in patients with suspected systemic sarcoidosis, especially with pulmonary or cardiac involvement. It can provide valuable information to the site of involvement by the disease and selection of more surgically accessible sites for biopsy.

If the diagnosis remains uncertain, biopsies of the meninges, brain or spinal cord may be indicated.[10] However, biopsies of the skin, lymph node, and lung are less risky and thus, are more preferred. A biopsy may also be considered for patients who do not respond to therapy.

Treatment / Management

Given the inflammatory process, corticosteroids are the main treatment for neural sarcoidosis. For facial nerve palsy or aseptic meningitis, prednisone is given every day for 2 weeks usually. In cases of meningeal, parenchymal mass lesion or myopathy or neuropathy, prednisone should be given for at least 4 weeks. For deteriorating patients, intravenous (IV) methylprednisolone is given for 3 days followed by prednisone for 2 to 4 weeks. The steroid dose should be tapered over several months with follow up by a neurologist every 3 to 6 months.

Immunosuppressants may also be considered, such as cyclosporine, methotrexate, and cyclophosphamide.

Differential Diagnosis

Other differentials to consider for neurosarcoidosis include primary brain tumors, toxin ingestion, neuropathies secondary to monoclonal proliferation or paraproteinemic neuropathy, paraneoplastic neuropathy, vitamin deficiency, leptomeningeal carcinomatosis, multiple sclerosis, central nervous system (CNS) lymphoma, or autoimmune conditions like systemic lupus erythematosus.

Prognosis

Neurosarcoidosis may present as either a monophasic illness, a relapsing-remitting course, or as a progressive disease with episodes of deteriorations. It is not well known what the long-term effects of neurosarcoidosis are. Usually, patients with facial nerve palsy or other cranial mononeuropathies will improve. In contrast, cases with aseptic meningitis or meningeal/parenchymal mass lesions have a longer course. Hypothalamic vegetative symptoms rarely resolve although may respond to treatment.

Encephalopathy/vasculopathy tends to have a relapsing-remitting course with deterioration. Cases with hydrocephalus may either be asymptomatic or cause rapid deterioration. Remissions are possible in peripheral neuropathy and myopathy cases, however, the course usually is chronic and progressive.

Pearls and Other Issues

With a diagnosis of sarcoidosis, physicians should be careful to monitor the signs and symptoms of neurosarcoidosis, with the most common symptom being cranial neuropathy involving the facial nerve. However, although most cases resolve, it is important to provide follow-up care to monitor for evolving symptoms. Treatment involves steroids to stop the inflammatory response caused by systemic sarcoidosis.

Enhancing Healthcare Team Outcomes

An interprofessional approach to neurosarcoidosis is recommended.

Cases of neurosarcoidosis require an interprofessional effort because the disorder has diverse presentations and has no specific test to make a diagnosis. Given the systemic involvement associated with neurosarcoidosis, a variety of specialists should be consulted such as rheumatology, endocrinology, and pulmonology. Neurosurgery may be consulted as well for resection of CNS masses. However, biopsy/excision procedures that involve the CNS can be associated with severe consequences, and remain a treatment of last choice. Thus, resection should be deferred, unless the mass continues to enlarge after immunosuppression. For cases with hydrocephalus, a ventriculoperitoneal shunt may be placed, albeit the risk of infection. Patients on prolonged steroids may benefit a dietician consult to manage weight gain and to develop an exercise program and reduce bone loss. All patients started on corticosteroids need to be monitored for adverse effects by the pharmacist. As soon as symptoms subside, rapid tapering of the drug is recommended.[11]


  • Image 7102 Not availableImage 7102 Not available
    Case courtesy of A.Prof Frank Gaillard, Radiopaedia.org, rID: 17921
Attributed To: Case courtesy of A.Prof Frank Gaillard, Radiopaedia.org, rID: 17921

Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Neurosarcoidosis - Questions

Take a quiz of the questions on this article.

Take Quiz
What is the most common cranial nerve affected in patients with neurosarcoidosis?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 55-year-old female presents with an unremitting cough in addition to polyuria, polydipsia, and menstrual irregularities for the past few months. A chest x-ray shows perihilar lymphadenopathy. Biopsy of a lymph node reveals non-caseating granulomas. Which part of the brain most likely is affected that is causing her endocrinologic problems?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 45-year-old male presents to the clinic for cognitive decline and intense anxiety. A mental status exam reveals impaired recall. An MRI shows hydrocephalus with diffuse meningeal enhancement. Blood tests show an elevated erythrocyte sedimentation rate (ESR) and angiotensin-converting enzyme (ACE) along with increased liver function tests. What is the best next step in management?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 20-year-old female is admitted for chronic headaches for the past 4 months. Her vital signs are stable. The physical exam is remarkable for lymphadenopathy, erythema nodosum, ataxia, and right facial droop without facial sparing. An MRI with gadolinium shows abnormal signal intensities in the cerebellum and brainstem. A lumbar puncture reveals elevated protein and mild pleocytosis. If a lymph node biopsy is done, what is the most likely histopathology that would be seen?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 30-year-old female presents to the emergency department with chest pain and cough for the past 6 months. Over the past few weeks, however, she has developed painful vision loss, photophobia, and drooling on the right side of her face. She also has noticed that her cheeks have been swollen for the past few weeks. He vital signs are significant for a temperature of 100.4F. A physical exam reveals parotid gland enlargement, facial nerve palsy, and conjunctival hyperemia due to anterior uveitis. The erythrocyte sedimentation rate (ESR) is elevated. What is the most likely diagnosis?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Neurosarcoidosis - References

References

Burns TM, Neurosarcoidosis. Archives of neurology. 2003 Aug     [PubMed]
Stern BJ,Krumholz A,Johns C,Scott P,Nissim J, Sarcoidosis and its neurological manifestations. Archives of neurology. 1985 Sep     [PubMed]
Arkema EV,Grunewald J,Kullberg S,Eklund A,Askling J, Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden. The European respiratory journal. 2016 Dec     [PubMed]
Lacomis D, Neurosarcoidosis. Current neuropharmacology. 2011 Sep     [PubMed]
Nemni R,Galassi G,Cohen M,Hays AP,Gould R,Singh N,Bressman S,Gamboa ET, Symmetric sarcoid polyneuropathy: analysis of a sural nerve biopsy. Neurology. 1981 Oct     [PubMed]
Denny MC,Fotino AD, The Heerfordt-Waldenström syndrome as an initial presentation of sarcoidosis. Proceedings (Baylor University. Medical Center). 2013 Oct     [PubMed]
Niemer GW,Bolster MB,Buxbaum L,Judson MA, Carpal tunnel syndrome in sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG. 2001 Oct     [PubMed]
Colvin IB, Audiovestibular manifestations of sarcoidosis: a review of the literature. The Laryngoscope. 2006 Jan     [PubMed]
Reda HM,Taylor SW,Klein CJ,Boes CJ, A case of sensory ataxia as the presenting manifestation of neurosarcoidosis. Muscle     [PubMed]
Peeples DM,Stern BJ,Jiji V,Sahni KS, Germ cell tumors masquerading as central nervous system sarcoidosis. Archives of neurology. 1991 May     [PubMed]
Tana C,Wegener S,Borys E,Pambuccian S,Tchernev G,Tana M,Giamberardino MA,Silingardi M, Challenges in the diagnosis and treatment of neurosarcoidosis. Annals of medicine. 2015     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Clinical Neurology-Medical Student. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Clinical Neurology-Medical Student, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Clinical Neurology-Medical Student, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Clinical Neurology-Medical Student. When it is time for the Clinical Neurology-Medical Student board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Clinical Neurology-Medical Student.